InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Grund Nicholas. Officer active across 2 companies, notably Akebia Therapeutics, Inc.. In total, 5 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €63k. History available since 31 January 2024. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Grund Nicholas is a declarant linked to Akebia Therapeutics, Inc. and AMAG PHARMACEUTICALS INC., where the listed primary role is Chief Commercial Officer. The record shows 5 filings in total, and among the sampled recent filings, the period runs from 2016-01-05 to 2026-02-04, with EUR 62859 in sales and a modal transaction nature listed as Attribution.